Cas no 53297-70-4 (4-Amino-3-methylbenzenesulfonamide)
4-Amino-3-methylbenzenesulfonamide Chemical and Physical Properties
Names and Identifiers
-
- 4-Amino-3-methylbenzenesulfonamide
- 3-Methyl-4-aminobenzensulfonamide
- 4-Amino-3-methylbenzenesulphonamide
- 4-Amino-3-Methylbenzensulfonamide
- 3-Methyl-4-aminobenzenesulfonamide
- 4-Amino-3-methyl-Benzenesulfonamide
- Benzenesulfonamide, 4-amino-3-methyl-
- 4-amino-3-methylbenzene-1-sulfonamide
- 2-methyl-4-sulfamoylaniline
- 2-methyl-4-sulphamoylaniline
- IGQGXIVCGKMRAM-UHFFFAOYSA-N
- 4-Amino-3-methylbenzen
- TS-00232
- AKOS010017008
- MFCD00466840
- 4-amino-3-methylbenzenesulfonamide, AldrichCPR
- DTXSID40201418
- AMY23269
- CS-W022072
- AC-16754
- FT-0640144
- SCHEMBL878966
- L-Asparticaciddimethyl esterhydrochloride
- SY109702
- 53297-70-4
- EN300-45420
- 4-Amino-3-Methyl Benzenesulfonamide
- A18854
- 252562-03-1
- DS-0092
-
- MDL: MFCD00466840
- Inchi: 1S/C7H10N2O2S/c1-5-4-6(12(9,10)11)2-3-7(5)8/h2-4H,8H2,1H3,(H2,9,10,11)
- InChI Key: IGQGXIVCGKMRAM-UHFFFAOYSA-N
- SMILES: S(C1C=CC(=C(C)C=1)N)(N)(=O)=O
Computed Properties
- Exact Mass: 186.04600
- Monoisotopic Mass: 186.046
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 245
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: -0.2
- Topological Polar Surface Area: 94.6
Experimental Properties
- Color/Form: No data avaiable
- Density: 1.359
- Melting Point: 158-161°C
- Boiling Point: 409.3°C at 760 mmHg
- Flash Point: 201.3°C
- Refractive Index: 1.609
- PSA: 94.56000
- LogP: 2.58690
- Vapor Pressure: 0.0±1.0 mmHg at 25°C
4-Amino-3-methylbenzenesulfonamide Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Safety Instruction: S22; S26; S36/37/39
-
Hazardous Material Identification:
- Risk Phrases:R20/21/22
- Storage Condition:Store at room temperature
4-Amino-3-methylbenzenesulfonamide Customs Data
- HS CODE:2935009090
- Customs Data:
China Customs Code:
2935009090Overview:
2935009090 Other sulphonates(Acyl)amine. VAT:17.0% Tax refund rate:9.0% Regulatory conditions:nothing MFN tariff:6.5% general tariff:35.0%
Declaration elements:
Product Name, component content, use to
Summary:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%
4-Amino-3-methylbenzenesulfonamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-SS036-250mg |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 97% | 250mg |
¥235.0 | 2022-06-10 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-SS036-50mg |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 97% | 50mg |
¥90.0 | 2022-06-10 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-SS036-1g |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 97% | 1g |
¥536.0 | 2022-06-10 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | A843106-1g |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 98% | 1g |
429.30 | 2021-05-17 | |
| Fluorochem | 068331-1g |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 97% | 1g |
£59.00 | 2022-03-01 | |
| Fluorochem | 068331-10g |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 97% | 10g |
£240.00 | 2022-03-01 | |
| Fluorochem | 068331-25g |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 97% | 25g |
£530.00 | 2022-03-01 | |
| TRC | A613495-100mg |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 100mg |
$ 64.00 | 2023-04-19 | ||
| TRC | A613495-250mg |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 250mg |
$ 98.00 | 2023-04-19 | ||
| TRC | A613495-500mg |
4-Amino-3-methylbenzenesulfonamide |
53297-70-4 | 500mg |
$ 150.00 | 2023-04-19 |
4-Amino-3-methylbenzenesulfonamide Suppliers
4-Amino-3-methylbenzenesulfonamide Related Literature
-
A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
-
Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
-
Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
-
Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
-
5. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
Additional information on 4-Amino-3-methylbenzenesulfonamide
Introduction to 4-Amino-3-methylbenzenesulfonamide (CAS No. 53297-70-4)
4-Amino-3-methylbenzenesulfonamide, identified by the Chemical Abstracts Service Number (CAS No.) 53297-70-4, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This sulfonamide derivative has garnered attention due to its structural uniqueness and potential biological activities, making it a subject of extensive investigation in drug discovery and development.
The molecular structure of 4-Amino-3-methylbenzenesulfonamide consists of a benzene ring substituted with an amino group at the 4-position and a sulfonamide moiety at the 3-position, further enhanced by a methyl group at the 3-position. This specific arrangement imparts distinct chemical and pharmacological properties, positioning it as a valuable scaffold for designing novel therapeutic agents.
In recent years, sulfonamide derivatives have been extensively studied for their antimicrobial, anti-inflammatory, and anticancer properties. The presence of both amino and sulfonamide functional groups in 4-Amino-3-methylbenzenesulfonamide suggests potential interactions with biological targets, such as enzymes and receptors, which are critical for modulating disease pathways. This dual functionality has opened up avenues for exploring its efficacy in treating various medical conditions.
One of the most compelling aspects of 4-Amino-3-methylbenzenesulfonamide is its role in the development of targeted therapies. Researchers have been particularly interested in its ability to inhibit specific enzymes involved in cancer progression. For instance, studies have indicated that sulfonamide compounds can interfere with the activity of tyrosine kinases, which are pivotal in signal transduction pathways that drive tumor growth. The structural features of 4-Amino-3-methylbenzenesulfonamide make it a promising candidate for designing inhibitors that selectively target these enzymes without affecting normal cellular processes.
Furthermore, the compound's potential application in treating inflammatory diseases has also been explored. Sulfonamides are known to exhibit anti-inflammatory effects by modulating the production of pro-inflammatory cytokines. The unique structural configuration of 4-Amino-3-methylbenzenesulfonamide may enhance its ability to interact with inflammatory pathways, offering a new therapeutic approach for conditions such as rheumatoid arthritis and inflammatory bowel disease.
The synthesis of 4-Amino-3-methylbenzenesulfonamide involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, including catalytic hydrogenation and nucleophilic substitution reactions, have been employed to construct the desired molecular framework. These synthetic strategies not only highlight the compound's complexity but also underscore the importance of skilled chemists in developing efficient synthetic routes for pharmaceutical intermediates.
Recent advancements in computational chemistry have further enhanced the understanding of 4-Amino-3-methylbenzenesulfonamide's pharmacological properties. Molecular docking studies have been conducted to predict its binding affinity to various biological targets, providing insights into its potential therapeutic applications. These computational approaches complement experimental investigations by offering rapid and cost-effective screening of drug-like compounds.
The safety profile of 4-Amino-3-methylbenzenesulfonamide is another critical aspect that has been thoroughly evaluated. Preclinical studies have assessed its toxicity, solubility, and metabolic stability, providing essential data for determining its suitability for further clinical development. The compound has demonstrated moderate solubility in water and organic solvents, which is favorable for formulation into various dosage forms.
In conclusion, 4-Amino-3-methylbenzenesulfonamide (CAS No. 53297-70-4) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and potential biological activities make it a valuable compound for drug discovery efforts aimed at treating cancer, inflammation, and other diseases. As research continues to uncover new therapeutic applications, this sulfonamide derivative is poised to play a crucial role in the development of next-generation medications.
53297-70-4 (4-Amino-3-methylbenzenesulfonamide) Related Products
- 34684-45-2(5-amino-2,4-dimethylbenzene-1-sulfonamide)
- 101251-33-6(3-Amino-4,5-dimethylbenzene-1-sulfonamide)
- 10311-44-1(3-amino-2,4-dimethylbenzene-1-sulfonamide)
- 6274-28-8(3-amino-4-methylbenzene-1-sulfonamide)
- 609-55-2(2-amino-5-methylbenzene-1-sulfonamide)
- 37559-29-8(3-amino-4-ethylbenzene-1-sulfonamide)
- 100142-87-8(4-(4-aminophenyl)benzene-1-sulfonamide)
- 252562-03-1(Acetamide,N-[4-(aminosulfonyl)-2-methylphenyl]-)
- 55825-25-7(1,3-Benzenedisulfonamide,2-amino-5-methyl-)
- 194020-05-8(Benzenesulfonamide,2-amino-3-ethyl-)